PL392397A1 - Modulatory funkcji zmutowanego białka CFTR oraz zastosowanie modulatorów w leczeniu chorób związanych z zaburzeniami w prawidłowym funkcjonowaniu białka CFTR - Google Patents

Modulatory funkcji zmutowanego białka CFTR oraz zastosowanie modulatorów w leczeniu chorób związanych z zaburzeniami w prawidłowym funkcjonowaniu białka CFTR

Info

Publication number
PL392397A1
PL392397A1 PL392397A PL39239710A PL392397A1 PL 392397 A1 PL392397 A1 PL 392397A1 PL 392397 A PL392397 A PL 392397A PL 39239710 A PL39239710 A PL 39239710A PL 392397 A1 PL392397 A1 PL 392397A1
Authority
PL
Poland
Prior art keywords
modulators
cftr protein
treatment
diseases associated
functional
Prior art date
Application number
PL392397A
Other languages
English (en)
Other versions
PL221889B1 (pl
Inventor
Piotr Zielenkiewicz
Grzegorz Wieczorek
Norbert Odolczyk
Aleksander Edelman
Danielle Tondelier
Janine Fritsch
Original Assignee
Instytut Biochemii I Biofizyki, Polska Akademia Nauk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instytut Biochemii I Biofizyki, Polska Akademia Nauk filed Critical Instytut Biochemii I Biofizyki, Polska Akademia Nauk
Priority to PL392397A priority Critical patent/PL221889B1/pl
Priority to CN201180048679.6A priority patent/CN103228632B/zh
Priority to PL11736202T priority patent/PL2616444T3/pl
Priority to SI201130667T priority patent/SI2616444T1/sl
Priority to EP11736202.0A priority patent/EP2616444B1/en
Priority to PT117362020T priority patent/PT2616444E/pt
Priority to CN201410598509.0A priority patent/CN104478800A/zh
Priority to DK11736202.0T priority patent/DK2616444T3/en
Priority to PCT/PL2011/000060 priority patent/WO2012036573A2/en
Priority to NZ609204A priority patent/NZ609204A/en
Priority to MX2013002895A priority patent/MX2013002895A/es
Priority to CN201410601165.4A priority patent/CN104496840A/zh
Priority to NZ700827A priority patent/NZ700827A/en
Priority to HUE11736202A priority patent/HUE026271T2/en
Priority to EP14185333.3A priority patent/EP2816035A3/en
Priority to KR1020137009595A priority patent/KR20140023866A/ko
Priority to MX2014011075A priority patent/MX356714B/es
Priority to CN201410601164.XA priority patent/CN104478882A/zh
Priority to EP14185332.5A priority patent/EP2816034B1/en
Priority to NZ700818A priority patent/NZ700818A/en
Priority to CA2811265A priority patent/CA2811265C/en
Priority to AU2011302715A priority patent/AU2011302715B2/en
Priority to JP2013529094A priority patent/JP5926731B2/ja
Priority to ES11736202.0T priority patent/ES2553628T3/es
Priority to US13/822,584 priority patent/US20130303761A1/en
Priority to EP14185330.9A priority patent/EP2826771B1/en
Publication of PL392397A1 publication Critical patent/PL392397A1/pl
Priority to IL225166A priority patent/IL225166A/en
Priority to IL235014A priority patent/IL235014A/en
Priority to IL235013A priority patent/IL235013A0/en
Priority to IL235015A priority patent/IL235015A0/en
Priority to US14/829,234 priority patent/US20160000778A1/en
Priority to JP2015163655A priority patent/JP6284914B2/ja
Priority to JP2015163661A priority patent/JP6173393B2/ja
Priority to HRP20151224TT priority patent/HRP20151224T1/hr
Priority to CY20151101051T priority patent/CY1117249T1/el
Priority to US14/969,573 priority patent/US10398665B2/en
Priority to US14/969,598 priority patent/US10420738B2/en
Priority to US14/969,609 priority patent/US10463639B2/en
Publication of PL221889B1 publication Critical patent/PL221889B1/pl

Links

PL392397A 2010-09-14 2010-09-14 Zastosowanie modulatora funkcji zmutowanego białka CFTR lub jego farmaceutycznie akceptowalnej pochodnej do wytwarzania leku do leczenia mukowiscydozy PL221889B1 (pl)

Priority Applications (38)

Application Number Priority Date Filing Date Title
PL392397A PL221889B1 (pl) 2010-09-14 2010-09-14 Zastosowanie modulatora funkcji zmutowanego białka CFTR lub jego farmaceutycznie akceptowalnej pochodnej do wytwarzania leku do leczenia mukowiscydozy
CA2811265A CA2811265C (en) 2010-09-14 2011-06-20 Compounds as modulators of a mutant cftr protein and their use for treating diseases associated with cftr protein malfunction
EP14185333.3A EP2816035A3 (en) 2010-09-14 2011-06-20 Compounds as modulators of a mutant CFTR protein and their use for treating diseases associated with CFTR protein malfunction
SI201130667T SI2616444T1 (sl) 2010-09-14 2011-06-20 Spojine kot modulatorji mutantnega cftr proteina in njihova uporaba za zdravljenje bolezni, povezanih s cftr proteinsko okvaro
EP11736202.0A EP2616444B1 (en) 2010-09-14 2011-06-20 Compounds as modulators of a mutant cftr protein and their use for treating diseases associated with cftr protein malfunction
PT117362020T PT2616444E (pt) 2010-09-14 2011-06-20 Compostos como moduladores de uma proteína cftr mutante e seu uso para tratar doenças associadas à disfunção da proteína cftr
CN201410598509.0A CN104478800A (zh) 2010-09-14 2011-06-20 作为突变cftr蛋白的调节剂的化合物及其在治疗与cftr蛋白失常相关的疾病中的用途
DK11736202.0T DK2616444T3 (en) 2010-09-14 2011-06-20 Compounds as modulators of a mutant CFTR protein and their use in the treatment of diseases associated with CFTR protein malfunction
PCT/PL2011/000060 WO2012036573A2 (en) 2010-09-14 2011-06-20 Compounds as modulators of a mutant cftr protein and their use for treating diseases associated with cftr protein malfunction
NZ609204A NZ609204A (en) 2010-09-14 2011-06-20 Compounds as modulators of a mutant cftr protein and their use for treating diseases associated with cftr protein malfunction
MX2013002895A MX2013002895A (es) 2010-09-14 2011-06-20 Compuestos como moduladores de una proteina cftr mutante y su uso para tratar enfermedades asociadas con las deficiencias de la proteina cftr.
CN201410601165.4A CN104496840A (zh) 2010-09-14 2011-06-20 作为突变cftr蛋白的调节剂的化合物及其在治疗与cftr蛋白失常相关的疾病中的用途
NZ700827A NZ700827A (en) 2010-09-14 2011-06-20 Compounds as modulators of a mutant cftr protein and their use for treating diseases associated with cftr protein malfunction
HUE11736202A HUE026271T2 (en) 2010-09-14 2011-06-20 Mutant CFTR protein modulator compounds and their use for the treatment of diseases that interfere with CFTR protein function disorders
AU2011302715A AU2011302715B2 (en) 2010-09-14 2011-06-20 Compounds as modulators of a mutant CFTR protein and their use for treating diseases associated with CFTR protein malfunction
KR1020137009595A KR20140023866A (ko) 2010-09-14 2011-06-20 돌연변이 ｃｆｔｒ 단백질의 조절제로서의 화합물 및 ｃｆｔｒ 단백질 기능부전과 관련된 질환을 치료하기 위한 이의 용도
MX2014011075A MX356714B (es) 2010-09-14 2011-06-20 Compuestos como moduladores de una proteina cftr mutante y su uso para tratar enfermedades asociadas con las deficiencias de la proteina cftr.
CN201410601164.XA CN104478882A (zh) 2010-09-14 2011-06-20 作为突变cftr蛋白的调节剂的化合物及其在治疗与cftr蛋白失常相关的疾病中的用途
EP14185332.5A EP2816034B1 (en) 2010-09-14 2011-06-20 Compounds as modulators of a mutant cftr protein and their use for treating diseases associated with cftr protein malfunction
CN201180048679.6A CN103228632B (zh) 2010-09-14 2011-06-20 作为突变cftr蛋白的调节剂的化合物及其在治疗与cftr蛋白失常相关的疾病中的用途
NZ700818A NZ700818A (en) 2010-09-14 2011-06-20 Compounds as modulators of a mutant cftr protein and their use for treating diseases associated with cftr protein malfunction
PL11736202T PL2616444T3 (pl) 2010-09-14 2011-06-20 Związki będące modulatorami zmutowanego białka CFTR oraz ich zastosowanie w leczeniu chorób związanych z zaburzeniami w funkcjonowaniu białka CFTR
JP2013529094A JP5926731B2 (ja) 2010-09-14 2011-06-20 変異ｃｆｔｒタンパク質の修飾因子としての化合物及びｃｆｔｒタンパク質異常に関連する病気の治療へのその使用
ES11736202.0T ES2553628T3 (es) 2010-09-14 2011-06-20 Compuestos como moduladores de una proteína CFTR mutante y su uso para el tratamiento de enfermedades asociadas con el mal funcionamiento de la proteína CFTR
US13/822,584 US20130303761A1 (en) 2010-09-14 2011-06-20 Compounds as modulators of a mutant cftr protein and their use for treating diseases associated with cftr protein malfunction
EP14185330.9A EP2826771B1 (en) 2010-09-14 2011-06-20 Compounds as modulators of a mutant CFTR protein and their use for treating diseases associated with CFTR protein malfunction
IL225166A IL225166A (en) 2010-09-14 2013-03-12 Compounds as modulators of cftr protein are neglected and their use in the treatment of diseases related to cftr protein dysfunction
IL235015A IL235015A0 (en) 2010-09-14 2014-10-06 Compounds as modulators of truncated cftr protein and their use in the treatment of diseases associated with cftr protein dysfunction
IL235013A IL235013A0 (en) 2010-09-14 2014-10-06 Compounds as modulators of truncated cftr protein and their use in the treatment of diseases associated with cftr protein dysfunction
IL235014A IL235014A (en) 2010-09-14 2014-10-06 Compounds as modulators of cftr protein are neglected and their use in the treatment of cftr protein-related diseases
US14/829,234 US20160000778A1 (en) 2010-09-14 2015-08-18 Compounds as modulators of a mutant cftr protein and their use for treating diseases associated with cftr protein malfunction
JP2015163655A JP6284914B2 (ja) 2010-09-14 2015-08-21 変異ｃｆｔｒタンパク質の修飾因子としての化合物
JP2015163661A JP6173393B2 (ja) 2010-09-14 2015-08-21 変異ｃｆｔｒタンパク質の修飾因子としての化合物
HRP20151224TT HRP20151224T1 (hr) 2010-09-14 2015-11-13 Tvari sa svojstvom modulatora mutiranog cftr proteina i njihova uporaba za lijeäśenje bolesti povezanih s nepravilnošä†u funkcije cftr proteina
CY20151101051T CY1117249T1 (el) 2010-09-14 2015-11-20 Ενωσεις ως διαμορφωτες μιας μεταλλαγμενης πρωτεϊνης cftr και χρησης αυτων για την θεραπεια νοσων που συνδεονται με δυσλειτουργια της πρωτεϊνης cftr
US14/969,573 US10398665B2 (en) 2010-09-14 2015-12-15 Compounds as modulators of a mutant CFTR protein and their use for treating diseases associated with CFTR protein malfunction
US14/969,598 US10420738B2 (en) 2010-09-14 2015-12-15 Compounds as modulators of a mutant CFTR protein and their use for treating diseases associated with CFTR protein malfunction
US14/969,609 US10463639B2 (en) 2010-09-14 2015-12-15 Compounds as modulators of a mutant CFTR protein and their use for treating diseases associated with CFTR protein malfunction

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL392397A PL221889B1 (pl) 2010-09-14 2010-09-14 Zastosowanie modulatora funkcji zmutowanego białka CFTR lub jego farmaceutycznie akceptowalnej pochodnej do wytwarzania leku do leczenia mukowiscydozy

Publications (2)

Publication Number Publication Date
PL392397A1 true PL392397A1 (pl) 2012-03-26
PL221889B1 PL221889B1 (pl) 2016-06-30

Family

ID=45891416

Family Applications (1)

Application Number Title Priority Date Filing Date
PL392397A PL221889B1 (pl) 2010-09-14 2010-09-14 Zastosowanie modulatora funkcji zmutowanego białka CFTR lub jego farmaceutycznie akceptowalnej pochodnej do wytwarzania leku do leczenia mukowiscydozy

Country Status (1)

Country Link
PL (1) PL221889B1 (pl)

Also Published As

Publication number Publication date
PL221889B1 (pl) 2016-06-30

Similar Documents

Publication Publication Date Title
IL265774B (en) Diagnosis, prevention and treatment of joint diseases
IL239368A0 (en) Sparing–ppar thiazolidinediones and combinations for the treatment of neurodegenerative diseases of the nervous system
EP2621499A4 (en) METHODS OF TREATING ALLERGIC DISEASES
ZA201207613B (en) Novel compounds for the treatment of diseases associated with amyloid or amyloid-like proteins
EP2799540A4 (en) HUMAN ARGINASE AND PEGYLATED HUMAN ARGINASE AND USE THEREOF
GB201302652D0 (en) Combination pharmaceutical composition and methods of treating diseases or conditions associated with neurodegenerative diseases
IL235013A0 (en) Compounds as modulators of truncated cftr protein and their use in the treatment of diseases associated with cftr protein dysfunction
HK1207860A1 (en) 2-phenyl-5-heterocyclyl-tetrahydro-2h-pyran-3-amine compounds for use in the treatment of diabetes and its associated disorders 2--5---2h--3-
EP2867239A4 (en) OXABICYCLOHEPTANES AND OXABICYCLOHEPTENES FOR THE TREATMENT OF DIABETES
WO2012021287A9 (en) Methods for the treatment and prevention of metabolic disorders
GB201001412D0 (en) Propolis and process for the treatment thereof
EP2575824A4 (en) METHODS FOR THE TREATMENT AND PREVENTION OF INFLAMMATORY DISEASES
HK1216721A1 (zh) 治療肝臟疾病或病狀的用途和方法
PL2555790T3 (pl) ZASTOSOWANIE LECZNICZE ß2-MIKROGLOBULINY
PT2455073E (pt) Combinação de substâncias para o tratamento de doentes com hipercolesterolemia e doenças relacionadas
IL223219A0 (en) Flufenoxine derivatives for the treatment and prevention of amiloyd pathologies
PL392397A1 (pl) Modulatory funkcji zmutowanego białka CFTR oraz zastosowanie modulatorów w leczeniu chorób związanych z zaburzeniami w prawidłowym funkcjonowaniu białka CFTR
PL392396A1 (pl) Modulatory funkcji zmutowanego białka CFTR oraz zastosowanie modulatorów w leczeniu chorób związanych z zaburzeniami w prawidłowym funkcjonowaniu białka CFTR
PL2356993T3 (pl) Lek do zmniejszenia cholesterolemii i triglicerydemii
IL231115A0 (en) Peptides for use in the treatment of diseases and disorders related to - 1 - il
AU2012900775A0 (en) Therapeutic and diagnostic agents
AU2011902500A0 (en) Treatment and diagnosis of epigenetic disorders and conditions
AU2011900677A0 (en) Therapeutic and diagnostic agents
GB201117269D0 (en) Peptoids for the phrophlyactic and therapeutic clearance of bacteria
AU2010900773A0 (en) Therapeutic and diagnostic agents